Products & ReviewLife Sciences

Ready-to-Use Lentiviral Packaging Plasmid Mix

CellectaCPCP-K2AAvailable: Worldwide

Cellecta’s Ready-to-Use Lentiviral Packaging Plasmid Mix allows the production of pseudoviral particles when mixed with second- or third-generation lentiviral vectors. The Packaging Plasmid Mix is a mixture of the human immunodeficiency virus (HIV) lentiviral packaging plasmid psPAX2 and the pMD2.G plasmid containing VSV-G. These plasmids provide all the necessary structural, regulatory, and replication proteins required to…

Cellecta

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review

Cellecta’s Ready-to-Use Lentiviral Packaging Plasmid Mix allows the production of pseudoviral particles when mixed with second- or third-generation lentiviral vectors.

The Packaging Plasmid Mix is a mixture of the human immunodeficiency virus (HIV) lentiviral packaging plasmid psPAX2 and the pMD2.G plasmid containing VSV-G. These plasmids provide all the necessary structural, regulatory, and replication proteins required to produce pseudotyped packaged lentiviral expression constructs when co-transfected with an HIV-based lentiviral expression construct (e.g. Cellecta pRSI shRNA expression constructs) into a producer 293T cell line (e.g. ATCC, Cat.# CRL-11268™). Pseudotyped lentiviral particles with VSV-G envelope protein can infect a variety of mammalian or non-mammalian, dividing or non-dividing cells. The kit contains 250 µg of lentiviral packaging plasmid mix that will be sufficient for 25 transfections in 10-cm culture plates.

Cellecta’s packaging mix contains tested anion-exchange purified packaging plasmids pre-mixed at the proper ratio for optimal production of packaged VSV-g pseudotyped lentiviral particles. This reagent is used in conjunction with HEK 293T cells.

The Ready-to-Use Lentiviral Packaging Plasmid Mix is compatible with most commercially-available second- and third-generation lentiviral vectors.

Product Overview

Links